Quest Diagnostics (DGX) Oct IV elevated at 43 into Q3 EPS
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $197.18 +1.86%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.7%
Revenue Growth %: +8.0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.7%
Revenue Growth %: +8.0%
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) October call option implied volatility is at 43, November is at 26; compared to its 52-week range of 13 to 31 into the expected release of Q3 results on October 19.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Qualcomm (QCOM) June 26 weekly 200 and 230 calls active into investor meeting
- Varonis Said To Weigh Sale After Takeover Interest - Bloomberg
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
